Focusing in on Novel Oral Systemic Therapies for Moderate Plaque Psoriasis

00:00 Introduction

03:15 The role of APP’s in getting patients access to dermatological care.

06:06 Managing patients with suboptimal controlled plaque psoriasis

13:05 Breaking down barriers to access new treatments for plaque psoriasis.

20:23 Deciding between oral and injectable systemic therapies.

24:25 The mechanism of action of TYK-2 inhibitors

28:24 The safety profile of deucravacitinib

33:14 Monitoring your patients with plaque psoriasis

38:50 Outro